Latest News

Flaw in Alzheimer's drug trial test, research suggests

New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Sensors used to monitor dangerous hits on football field

  • 'Abandoned' stroke survivors need better longer-term care, expert says

  • Black Republicans put most faith in US government

  • Bedside caregivers: Research shows opening visitation access improves patient satisfaction

  • Expectant mothers with epilepsy face tough choices over their medication

  • Possible cause of common dementia found, opening avenues for treatment

  • Lou Gehrig's disease study: Renewing brain's aging support cells may help neurons survive

  • Minutes in Criminal Procedures: Writing Style Influences Judges

  • Greater inequality within UK, USA than some developing countries, trade 'footprint' shows

  • Even mild depressive symptoms result in poorer lumbar spinal stenosis surgery outcome

  •